February 18, 2021
When India went into lockdown in March 2020, the fear of Covid-19 swiftly spreading through a densely populated country of 1.3 billion people was dangerously real.
A harsh lockdown, one of the strictest in the world, created a humanitarian crisis of its own, pushing millions of migrant workers to take arduous journeys back home on foot. But the possible catastrophic impact of the pandemic was considered greater in magnitude by the government.
Nearly 11 months on, the Covid-19 infections and fatalities in India tell a different story.
In the early days of the pandemic in the country, for instance, the projected fatalities from the viral infection were believed to be 4 million. But as of Feb. 18, deaths from Covid-19 in India stand at 155,913, less than 10% of the estimate.
Updated:
U.K. approves trial exposing volunteers to virus; Singapore receives Moderna COVID-19 vaccines
Share Article
AAA
U.K. approves trial exposing volunteers to virus; Singapore receives Moderna COVID-19 vaccines
Four cases of the SARS-CoV-2 variant strain from South Africa and one case of the Brazil variant have been detected in India, the Health Ministry confirmed on February 16, 2021.
Stating that India should continue its vigil to contain the COVID virus despite the fall in number of active COVID cases in India and vaccines member (health) NITI Aayog V.K. Paul, noted that India is now giving COVID vaccines to 24 countries.
Thermo Fisher to make COVID-19 RT-PCR testing kits in Bengaluru
Coronavirus in India: The new facility will have a capacity to manufacture up to 10 million tests every month. CoviPath COVID-19 RT-PCR Kit has been approved by the ICMR and DCGI
PB Jayakumar | February 17, 2021 | Updated 10:14 IST
Thermo Fisher to make coronavirus test kits in India
Thermo Fisher Scientific, one of the leading global medical devices manufacturers, will produce COVID-19 testing kits and diagnostic solutions at its manufacturing facility in Bengaluru for the Indian market.
The new facility will have a capacity to manufacture up to 10 million tests every month. This facility will be instrumental in ensuring access to affordable testing kits while maintaining global quality standards, said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.
Thermo Fisher to make COVID-19 RT-PCR testing kits in Bengaluru businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.